Kelyniam Global, Inc.
Kelyniam Global, Inc. (KLYG) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
klyg · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kelyniam Global, Inc. (KLYG) measures how much investors pay for each dollar of the company's trailing earnings. KLYG's current PE ratio of N/A is calculated by dividing its stock price of $0.14 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%28.7x
MedianQ3 · 75%185.9x
Max
At N/A, KLYG's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kelyniam Global, Inc.You KLYG | $2M | N/A | — | -$0.00 |
 Algernon Pharmaceuticals Inc. AGNPF | $2M | N/A | — | -$0.58 |
 Caduceus Software Systems Corp. CSOC | $1M | N/A | — | -$0.01 |
 Genix Pharmaceuticals Corporation GENPF | $1M | N/A | — | -$0.01 |
 Imagion Biosystems Limited IBXXF | $7M | N/A | — | -$0.02 |
 Indo Global Exchange(s) PTE, Ltd. IGEX | $2M | N/A | — | -$0.00 |
 Medical Supply International USA, Inc. MSIU | $0M | 193.79x | — | $0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.00 | — | |
2024-12-31 FY2024 | — | $-0.02 | — | |
2023-12-31 FY2023 | — | $-0.01 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | 12.64x | $0.01 | -55.9% | |
2020-12-31 FY2020 | 28.66x | $0.01 | — | |
2019-12-31 FY2019 | — | $-0.01 | — | |
2018-12-31 FY2018 | — | $-0.00 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kelyniam Global, Inc. (KLYG) measures how much investors pay for each dollar of the company's trailing earnings. KLYG's current PE ratio of N/A is calculated by dividing its stock price of $0.14 by its TTM earnings per share of -$0.00.
Frequently asked questions
KLYG pe ratio · 6 questionsKLYG's current PE ratio is N/A as of 2026-06-15, based on a stock price of $0.14 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via KLYG's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kelyniam Global, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15